Skip to main content
. 2020 Oct 30;17(5):492–499. doi: 10.4274/tjps.galenos.2019.76402

Figure 4.

Figure 4

Cell viability of formulations after 48 h incubation. A: MCF-7 cells, B: MDA-MB-231 cells (n=3, mean ± SE). *Indicates significantly different from control (p<0.05)

SE: Standard error, TLM-NP: Telmisartan-loaded nanoparticles